Posted by: Market Watch in Market News 1 hour in the past Rapt Therapeutics mentioned Monday it plans to supply three million shares in its
Rapt Therapeutics mentioned Monday it plans to supply three million shares in its preliminary public providing priced at $12 to $14 every. The clinical-stage immunology-based biopharmaceutical firm would increase $42 million on the high of that vary. The corporate has utilized to record on Nasdaq below the ticker image “RAPT.” BMO Capital Markets, Wells Fargo and UBS are underwriters on the deal. Proceeds can be used to fund scientific trials and to growth different drug candidates, in addition to for different normal company functions. Market Pulse Tales are Fast-fire, brief information bursts on shares and markets as they transfer. Go to MarketWatch.com for extra data on this information.
Newest posts by Market Watch (see all)